Global Expansion

Imago Systems is actively strengthening its international presence through a series of strategic partnerships designed to accelerate commercialization and expand clinical adoption of both ICE Reveal and ICE Insight. These alliances not only open immediate entry into high-value markets but also establish scalable frameworks for long-term growth and global execution.

Argentina & Latin America – Through its partnership with LATAM Partners, Imago is preparing for the commercialization of Reveal 1.0. Regulatory submission to ANMAT (Argentina’s health authority) is underway, providing a clear path toward market authorization. In parallel, commercialization plans are being refined with defined pathways to TAM/SAM/SOM expansion, ensuring Reveal’s initial launch creates momentum for broader adoption across Latin America.

Egypt & Middle East – Imago recently signed a Sole Agency Agreement with Noble Intelligent Medical Solutions (Cairo, Egypt), granting exclusive rights to distribute both Reveal and Insight across Egypt and the broader Middle East. This collaboration includes plans for localized validation studies with leading mammographers and interventional cardiologists, an important step in building regional clinical credibility and accelerating adoption across diverse healthcare systems.

By establishing these partnerships, Imago is creating a solid footprint in two strategically important regions—Latin America and the Middle East—while laying the groundwork for future expansion into Europe, Asia, and beyond. Each agreement reflects Imago’s broader commitment to building a truly global imaging platform, ensuring that patients and providers worldwide gain access to transformative decision-support tools that improve detection, diagnosis, and outcomes in breast and cardiovascular care.

John Boney
Investor Relations
IMAGO SYSTEMS, INC.
john@imagosystems.com
19309 Winmeade Drive| Suite 217 | Lansdowne, VA 20176
www.imagosystems.com